Levels of PCT and IL-6 on day 1 were significantly higher in the VAP group when compared with the non-VAP group (P<0.05), while there was no statistically significant difference in the CRP levels between the groups on day 1 (P>0.05). This evidence concerns the gene IL6 and ventilator-associated pneumonia.